Concepts (117)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms | 11 | 2018 | 981 | 1.360 |
Why?
|
| Colonoscopy | 7 | 2012 | 279 | 1.310 |
Why?
|
| Mass Screening | 5 | 2012 | 636 | 1.050 |
Why?
|
| Adenoma | 7 | 2015 | 246 | 0.760 |
Why?
|
| Colonic Polyps | 4 | 2010 | 132 | 0.740 |
Why?
|
| Rectum | 6 | 2018 | 148 | 0.440 |
Why?
|
| Colonic Neoplasms | 6 | 2018 | 573 | 0.410 |
Why?
|
| Polyethylene Glycols | 2 | 2018 | 358 | 0.390 |
Why?
|
| Precancerous Conditions | 2 | 2015 | 200 | 0.390 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 2008 | 39 | 0.380 |
Why?
|
| Pyloric Antrum | 1 | 2008 | 4 | 0.310 |
Why?
|
| Gastric Fundus | 1 | 2008 | 7 | 0.310 |
Why?
|
| Cathartics | 1 | 2008 | 27 | 0.310 |
Why?
|
| Phosphates | 1 | 2008 | 160 | 0.290 |
Why?
|
| Spectrum Analysis | 3 | 2015 | 119 | 0.270 |
Why?
|
| Stomach Neoplasms | 1 | 2008 | 281 | 0.240 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2010 | 1363 | 0.230 |
Why?
|
| Kidney | 1 | 2008 | 1145 | 0.210 |
Why?
|
| Colitis, Microscopic | 2 | 2011 | 6 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 1043 | 0.190 |
Why?
|
| Early Detection of Cancer | 2 | 2015 | 415 | 0.160 |
Why?
|
| Aberrant Crypt Foci | 1 | 2018 | 7 | 0.160 |
Why?
|
| Laxatives | 1 | 2018 | 13 | 0.150 |
Why?
|
| Pancreatic Neoplasms | 2 | 2014 | 667 | 0.150 |
Why?
|
| Anticarcinogenic Agents | 1 | 2018 | 73 | 0.150 |
Why?
|
| Male | 15 | 2018 | 42254 | 0.140 |
Why?
|
| Colon | 2 | 2012 | 509 | 0.140 |
Why?
|
| Risk | 2 | 2008 | 657 | 0.140 |
Why?
|
| Risk Factors | 6 | 2012 | 5466 | 0.130 |
Why?
|
| Female | 14 | 2018 | 46014 | 0.130 |
Why?
|
| Humans | 21 | 2018 | 89073 | 0.130 |
Why?
|
| Prevalence | 2 | 2010 | 1240 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 2018 | 500 | 0.120 |
Why?
|
| Fatty Acid Synthases | 1 | 2014 | 8 | 0.120 |
Why?
|
| Aspirin | 1 | 2015 | 159 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 76 | 0.110 |
Why?
|
| Scattering, Radiation | 1 | 2013 | 116 | 0.110 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2015 | 242 | 0.110 |
Why?
|
| Tomography, Optical Coherence | 1 | 2014 | 136 | 0.110 |
Why?
|
| Sex Factors | 3 | 2012 | 1063 | 0.110 |
Why?
|
| Biopsy | 3 | 2015 | 1182 | 0.100 |
Why?
|
| Intestinal Mucosa | 3 | 2015 | 805 | 0.100 |
Why?
|
| Biomarkers, Tumor | 4 | 2018 | 1543 | 0.100 |
Why?
|
| Colitis, Collagenous | 1 | 2011 | 2 | 0.100 |
Why?
|
| Colitis, Lymphocytic | 1 | 2011 | 4 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2013 | 211 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 447 | 0.100 |
Why?
|
| Middle Aged | 9 | 2018 | 25865 | 0.090 |
Why?
|
| Sigmoidoscopy | 1 | 2010 | 36 | 0.090 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2009 | 157 | 0.090 |
Why?
|
| Microvessels | 1 | 2010 | 69 | 0.090 |
Why?
|
| Sex Distribution | 1 | 2010 | 171 | 0.090 |
Why?
|
| Aged | 8 | 2018 | 19078 | 0.090 |
Why?
|
| Incidence | 2 | 2011 | 1592 | 0.080 |
Why?
|
| Colectomy | 1 | 2010 | 172 | 0.080 |
Why?
|
| Intestinal Polyps | 1 | 2008 | 27 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 1239 | 0.070 |
Why?
|
| Helicobacter pylori | 1 | 2008 | 37 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 966 | 0.070 |
Why?
|
| Duodenum | 1 | 2008 | 103 | 0.070 |
Why?
|
| Smoking | 1 | 2011 | 620 | 0.070 |
Why?
|
| Age Factors | 2 | 2012 | 1867 | 0.070 |
Why?
|
| Chemoprevention | 2 | 2018 | 92 | 0.070 |
Why?
|
| Education, Medical, Continuing | 1 | 2007 | 105 | 0.070 |
Why?
|
| Carcinoma | 1 | 2009 | 443 | 0.070 |
Why?
|
| Adult | 6 | 2018 | 26508 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2007 | 168 | 0.060 |
Why?
|
| Esophagogastric Junction | 1 | 2004 | 34 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2015 | 1855 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2018 | 1715 | 0.050 |
Why?
|
| Gastroesophageal Reflux | 1 | 2004 | 122 | 0.050 |
Why?
|
| Exercise | 1 | 2004 | 322 | 0.050 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2000 | 16 | 0.050 |
Why?
|
| Dermatomyositis | 1 | 2000 | 18 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2000 | 73 | 0.040 |
Why?
|
| Time Factors | 1 | 2008 | 5320 | 0.040 |
Why?
|
| Placebo Effect | 1 | 2018 | 30 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2000 | 471 | 0.040 |
Why?
|
| Rats | 2 | 2014 | 4041 | 0.040 |
Why?
|
| Dinoprostone | 1 | 2015 | 70 | 0.030 |
Why?
|
| Glucuronosyltransferase | 1 | 2015 | 186 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 6777 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2015 | 148 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 136 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 186 | 0.030 |
Why?
|
| Prognosis | 2 | 2011 | 3773 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2013 | 202 | 0.030 |
Why?
|
| Light | 1 | 2013 | 292 | 0.030 |
Why?
|
| Microscopy | 1 | 2012 | 87 | 0.020 |
Why?
|
| Nanostructures | 1 | 2012 | 79 | 0.020 |
Why?
|
| Chromatin | 1 | 2014 | 397 | 0.020 |
Why?
|
| Genotype | 1 | 2015 | 1848 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2014 | 0.020 |
Why?
|
| Fiber Optic Technology | 1 | 2010 | 35 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2001 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1706 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 104 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2013 | 1097 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2752 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1755 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 337 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 1067 | 0.020 |
Why?
|
| Consumer Behavior | 1 | 2007 | 30 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 2362 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2015 | 4273 | 0.020 |
Why?
|
| Data Collection | 1 | 2007 | 375 | 0.020 |
Why?
|
| Gastroscopy | 1 | 2004 | 25 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3657 | 0.020 |
Why?
|
| Manometry | 1 | 2004 | 44 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 2863 | 0.010 |
Why?
|
| Animals | 2 | 2014 | 27324 | 0.010 |
Why?
|
| Monitoring, Ambulatory | 1 | 2004 | 32 | 0.010 |
Why?
|
| Esophagus | 1 | 2004 | 106 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2004 | 499 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2000 | 98 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2011 | 9003 | 0.010 |
Why?
|
| United States | 1 | 2007 | 6957 | 0.010 |
Why?
|